Clinical Trial Update: Eribulin in Combination With Cyclophosphamide in Patients With Solid Tumor Malignancies [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial of eribulin with cyclophosphamide in malignant solid tumors and metastatic/recurrent breast cancer; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Malignant Solid Tumor

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Eribulin (eribulin mesilate)

Snippet

Sponsor: University of California, San Francisco | Conditions: Malignant Solid Tumour, Breast Cancer Nos Metastatic Recurrent | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-02-03